N/A
N=287
Improving Goals of Care Discussion in Advanced Cancer Patients
Primary Stage IV Hepatobiliary · Esophageal · Colorectal Cancer · Glioblastoma · Cancer of Stomach
Bottom Line
View on ClinicalTrials.gov: NCT02374255 ↗Enrolled (actual)
287
Serious AEs
—
Results posted
Oct 2019
Primary outcome: Primary: Number of Participants Who Perceived Increased Goals of Care Discussions — 43; 34 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- GoC intervention (Behavioral)
- Age
- Adult, Older Adult · 21+ yrs
- Sex
- All
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Primary completion
- May 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Who Perceived Increased Goals of Care Discussions |
43; 34 | — |
| PRIMARY Number of Patients Perception of Improved Goals of Care Discussions |
70; 65 | — |
| SECONDARY Communication Skills Training |
3.7; 2.2 | — |
Summary
The goal of this study is to increase and improve Goals of Care discussions for advanced cancer patients by training medical oncologists to conduct these discussions. The investigators will evaluate the GoC discussion's effects on patient satisfaction, receipt of treatment in line with preferences, use of aggressive treatment, and oncologist communication skill.
Eligibility Criteria
Inclusion Criteria
- Men or women who are at least 21 years of age who have been diagnosed within one month with a pathologically confirmed advanced cancer who have an average of <2 y life expectancy (primary stage IV hepatobiliary, esophageal, colorectal, glioblastoma, gastric, pancreatic, melanoma, head & neck, or stage III or IV lung or pancreatic cancers) and are being treated at one of the participating hospital sites and speak English or Spanish.
- Oncologists who treat at least 2 advanced cancer patients per month at a study participating hospital will be enrolled into the study.
Exclusion Criteria
- Patients who have seen an oncologist after undergoing first line treatment imaging as this group has a higher likelihood of having received a goals of care discussion.
- Men or women who do not speak English or Spanish will be excluded.
Data sourced from ClinicalTrials.gov (NCT02374255). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.